NCT05821816

Brief Summary

The aim of the study is to evaluate whether a non-invasive brain stimulation technique (Transcranial Direct Current Stimulation) can influence the secondary neurodegeneration observed after a stroke (assessed based on serum concentration of neurofilaments) and can improve the functional outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 2, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 7, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

March 13, 2025

Status Verified

September 1, 2024

Enrollment Period

1.9 years

First QC Date

April 7, 2023

Last Update Submit

March 10, 2025

Conditions

Keywords

StrokeRehabilitationtDCSNeurofilamentNeurofilament light chainNfLTranscranial direct current stimulation

Outcome Measures

Primary Outcomes (1)

  • To assess the change of blood value of Neurofilament light chain (NfL)

    Evaluation of neurodegeneration after stroke

    Initial assessment: after enrollment. Intermediate evaluation after 6 weeks. Final evaluation after 12 weeks since enrollment

Secondary Outcomes (8)

  • To assess the change of the Fugl-Meyer Assessment for upper extremity (FMA-UE)

    Initial assessment: after enrollment. Intermediate evaluation after 6 weeks. Final evaluation after 12 weeks since enrollment

  • To assess the change of Modified Ashwort Scale (MAS)

    Initial assessment: after enrollment. Intermediate evaluation after 6 weeks. Final evaluation after 12 weeks since enrollment

  • To assess the change of The Rivermead Mobility Index (RMI)

    Initial assessment: after enrollment. Intermediate evaluation after 6 weeks. Final evaluation after 12 weeks since enrollment

  • To assess the change of Barthel Index (BI)

    Initial assessment: after enrollment. Intermediate evaluation after 6 weeks. Final evaluation after 12 weeks since enrollment

  • To assess the change of Functional Ambulation Categories (FAC)

    Initial assessment: after enrollment. Intermediate evaluation after 6 weeks. Final evaluation after 12 weeks since enrollment

  • +3 more secondary outcomes

Study Arms (2)

Experimental Group

EXPERIMENTAL

Standard rehabilitative treatment for stroke + tDCS

Device: tDCSOther: Conventional rehabilitative treatment

Control Group

ACTIVE COMPARATOR

Only standard rehabilitative treatment for stroke

Other: Conventional rehabilitative treatment

Interventions

tDCSDEVICE

Use of Transcranial direct current stimulation for 20 minutes per day, 5 days a week, at 2mA

Experimental Group

Physiotherapy treatment consisting in two treatments per day of 40 minutes each

Control GroupExperimental Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • partecipants with a first episode of ischemic or hemorrhagic stroke
  • partecipants must be enrolled within 30 days from the stroke

You may not qualify if:

  • partecipants with previous episodes of ischemic or hemorrhagic stroke (evaluation by neuroimaging required)
  • uncooperative patients
  • medically unstable patients
  • partecipants with any other neurodegenerative diseases
  • epilepsies
  • multiple ischemic lesions
  • encephalic trunk ischemic lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

I.R.C.C.S. Fondazione Santa Lucia

Roma, Italy, 00179, Italy

Location

Related Publications (21)

  • Allman C, Amadi U, Winkler AM, Wilkins L, Filippini N, Kischka U, Stagg CJ, Johansen-Berg H. Ipsilesional anodal tDCS enhances the functional benefits of rehabilitation in patients after stroke. Sci Transl Med. 2016 Mar 16;8(330):330re1. doi: 10.1126/scitranslmed.aad5651. Epub 2016 Mar 16.

    PMID: 27089207BACKGROUND
  • Barro C, Chitnis T, Weiner HL. Blood neurofilament light: a critical review of its application to neurologic disease. Ann Clin Transl Neurol. 2020 Dec;7(12):2508-2523. doi: 10.1002/acn3.51234. Epub 2020 Nov 4.

    PMID: 33146954BACKGROUND
  • Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, Mourdoukoutas AP, Kronberg G, Truong D, Boggio P, Brunoni AR, Charvet L, Fregni F, Fritsch B, Gillick B, Hamilton RH, Hampstead BM, Jankord R, Kirton A, Knotkova H, Liebetanz D, Liu A, Loo C, Nitsche MA, Reis J, Richardson JD, Rotenberg A, Turkeltaub PE, Woods AJ. Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Brain Stimul. 2016 Sep-Oct;9(5):641-661. doi: 10.1016/j.brs.2016.06.004. Epub 2016 Jun 15.

    PMID: 27372845BACKGROUND
  • Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. doi: 10.1093/ptj/67.2.206.

    PMID: 3809245BACKGROUND
  • Bolognini N, Vallar G, Casati C, Latif LA, El-Nazer R, Williams J, Banco E, Macea DD, Tesio L, Chessa C, Fregni F. Neurophysiological and behavioral effects of tDCS combined with constraint-induced movement therapy in poststroke patients. Neurorehabil Neural Repair. 2011 Nov-Dec;25(9):819-29. doi: 10.1177/1545968311411056. Epub 2011 Jul 29.

    PMID: 21803933BACKGROUND
  • Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud. 1991 Apr-Jun;13(2):50-4. doi: 10.3109/03790799109166684.

    PMID: 1836787BACKGROUND
  • Di Lazzaro V, Dileone M, Capone F, Pellegrino G, Ranieri F, Musumeci G, Florio L, Di Pino G, Fregni F. Immediate and late modulation of interhemipheric imbalance with bilateral transcranial direct current stimulation in acute stroke. Brain Stimul. 2014 Nov-Dec;7(6):841-8. doi: 10.1016/j.brs.2014.10.001. Epub 2014 Oct 13.

    PMID: 25458712BACKGROUND
  • Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13-31.

    PMID: 1135616BACKGROUND
  • Gattringer T, Pinter D, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, Pichler A, Barro C, Grobke S, Voortman M, Pirpamer L, Hofer E, Ropele S, Schmidt R, Kuhle J, Fazekas F, Khalil M. Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017 Nov 14;89(20):2108-2114. doi: 10.1212/WNL.0000000000004645. Epub 2017 Oct 18.

    PMID: 29046363BACKGROUND
  • Gentil BJ, Tibshirani M, Durham HD. Neurofilament dynamics and involvement in neurological disorders. Cell Tissue Res. 2015 Jun;360(3):609-20. doi: 10.1007/s00441-014-2082-7. Epub 2015 Jan 8.

    PMID: 25567110BACKGROUND
  • Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984 Jan;64(1):35-40. doi: 10.1093/ptj/64.1.35.

    PMID: 6691052BACKGROUND
  • Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z.

    PMID: 30171200BACKGROUND
  • Khedr EM, Shawky OA, El-Hammady DH, Rothwell JC, Darwish ES, Mostafa OM, Tohamy AM. Effect of anodal versus cathodal transcranial direct current stimulation on stroke rehabilitation: a pilot randomized controlled trial. Neurorehabil Neural Repair. 2013 Sep;27(7):592-601. doi: 10.1177/1545968313484808. Epub 2013 Apr 22.

    PMID: 23609526BACKGROUND
  • MAHONEY FI, BARTHEL DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965 Feb;14:61-5. No abstract available.

    PMID: 14258950BACKGROUND
  • Sattler V, Acket B, Raposo N, Albucher JF, Thalamas C, Loubinoux I, Chollet F, Simonetta-Moreau M. Anodal tDCS Combined With Radial Nerve Stimulation Promotes Hand Motor Recovery in the Acute Phase After Ischemic Stroke. Neurorehabil Neural Repair. 2015 Sep;29(8):743-54. doi: 10.1177/1545968314565465. Epub 2015 Jan 7.

    PMID: 25567120BACKGROUND
  • Ziemann U, Paulus W, Nitsche MA, Pascual-Leone A, Byblow WD, Berardelli A, Siebner HR, Classen J, Cohen LG, Rothwell JC. Consensus: Motor cortex plasticity protocols. Brain Stimul. 2008 Jul;1(3):164-82. doi: 10.1016/j.brs.2008.06.006. Epub 2008 Jul 1.

    PMID: 20633383BACKGROUND
  • Gladstone DJ, Danells CJ, Black SE. The fugl-meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair. 2002 Sep;16(3):232-40. doi: 10.1177/154596802401105171.

    PMID: 12234086BACKGROUND
  • Rech KD, Salazar AP, Marchese RR, Schifino G, Cimolin V, Pagnussat AS. Fugl-Meyer Assessment Scores Are Related With Kinematic Measures in People with Chronic Hemiparesis after Stroke. J Stroke Cerebrovasc Dis. 2020 Jan;29(1):104463. doi: 10.1016/j.jstrokecerebrovasdis.2019.104463. Epub 2019 Nov 15.

    PMID: 31740027BACKGROUND
  • Park GT, Kim M. Correlation between mobility assessed by the Modified Rivermead Mobility Index and physical function in stroke patients. J Phys Ther Sci. 2016 Aug;28(8):2389-92. doi: 10.1589/jpts.28.2389. Epub 2016 Aug 31.

    PMID: 27630440BACKGROUND
  • Bloch ML, Jonsson LR, Kristensen MT. Introducing a Third Timed Up & Go Test Trial Improves Performances of Hospitalized and Community-Dwelling Older Individuals. J Geriatr Phys Ther. 2017 Jul/Sep;40(3):121-126. doi: 10.1519/JPT.0000000000000080.

    PMID: 26881947BACKGROUND
  • Ibeneme SC, Eze JC, Okonkwo UP, Ibeneme GC, Fortwengel G. Evaluating the discriminatory power of the velocity field diagram and timed-up-and-go test in determining the fall status of community-dwelling older adults: a cross-sectional observational study. BMC Geriatr. 2022 Aug 11;22(1):658. doi: 10.1186/s12877-022-03282-2.

    PMID: 35948869BACKGROUND

MeSH Terms

Conditions

StrokeCharcot-Marie-Tooth disease, Type 1F

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Stefano Brunelli, MD

    I.R.C.C.S. Fondazione Santa Lucia, Roma, Italy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Physiatrist of the Operative Unit 4 for inpatient rehabilitation

Study Record Dates

First Submitted

April 7, 2023

First Posted

April 20, 2023

Study Start

March 2, 2023

Primary Completion

February 1, 2025

Study Completion

February 1, 2025

Last Updated

March 13, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices)

Shared Documents
ICF
Time Frame
Beginning 3 months and ending 5 years following article publication
Access Criteria
Proposals should be directed to the personal corrisponding author's mail address.

Locations